Skip to main content
OpenTrials
Completed

NCT Number: NCT01240057

Tracheal Occlusion To Accelerate Lung Growth (TOTAL) Trial for Severe Pulmonary Hypoplasia

This trial investigates whether prenatal intervention improves survival rate of fetuses with isolated congenital diaphragmatic hernia and severe pulmonary hypoplasia, as compared to expectant management during pregnancy, both followed by standardized postnatal care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Mater Mother's Hospital, Brisbane, Queensland, Australia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18 years or more, who are able to consent
  • Singleton pregnancy
  • Anatomically and chromosomally normal fetus
  • Left sided diaphragmatic hernia
  • Gestation at randomization prior to 29 wks plus 5 d (so that occlusion is done at the latest on 29 wks plus 6 d)
  • Estimated to have severe pulmonary hypoplasia, defined prenatally as: O/E LHR <25 %, irrespective of the liver position
  • Acceptance of randomization and the consequences for the further management during pregnancy and thereafter.
  • The patients must undertake the responsibility for either remaining close to, or at the FETO center, or being able to travel swiftly and within acceptable time interval to the FETO center until the balloon is removed.
  • Intended postnatal treatment center must subscribe to suggested guidelines for "standardized postnatal treatment".
  • Provide written consent to participate in this RCT

Exclusion criteria

  • Maternal contraindication to fetoscopic surgery or severe medical condition in pregnancy that make fetal intervention risk full
  • Technical limitations precluding fetoscopic surgery, such as severe maternal obesity, uterine fibroids or potentially others, not anticipated at the time of writing this protocol.
  • Preterm labour, cervix shortened (<15 mm at randomization) or uterine anomaly strongly predisposing to preterm labour, placenta previa
  • Patient age less than 18 years
  • Psychosocial ineligibility, precluding consent
  • Diaphragmatic hernia: right-sided or bilateral, major anomalies, isolated left-sided outside the O/E LHR limits for the inclusion criteria
  • Patient refusing randomization or to comply with return to FETO center during the time period the airways are occluded or for elective removal of the balloon

Treatment and study plan

fetal endoluminal tracheal occlusion

Procedure

percutaneous fetoscopy, positioning of endoluminal balloon at 27-30 weeks and whenever possible elective removal at 34 weeks

Other names: Balt Goldbal 2 balloon

watchful waiting during pregnancy

Other

pregnancy surveillance for fetal wellbeing, development of polyhydramnios and cervical shortening

Primary outcomes

  1. Survival at discharge from neonatal intensive care unit

    Time frame: at discharge from neonatal intensive care unit

    The baby can be discharged either alive (and then it qualifies as "surviving at discharge") or dead. Not discharged babies have not reached the primary endpoint.

Secondary outcomes

  1. prenatal increase in lung volume after FETO

    Time frame: prior to balloon removal

    volume of lung after occlusion

  2. grading of oxygen dependency

    Time frame: born >32 wks: between 28-56d of life; born <32wks: 36wks postmenstrual age

  3. occurrence of pulmonary hypertension

    Time frame: within first weeks of life

    determined by cardiac ultrasound

  4. number of days in Neonatal Intensive Care Unit (NICU)

    Time frame: within hospital stay

    As long as the baby is in the hospital, it is hospitalized either in NICU or in another, less intensive care unit.

    The number of days in NICU is an outcome variable, expressed in days.

  5. number of days of ventilatory support

    Time frame: within NICU stay

  6. presence of periventricular leucomalacia

    Time frame: 2 months of life

  7. presence of neonatal sepsis, intraventricular haemorrhage, retinopathy grade III or higher

    Time frame: within hospital stay

  8. number of days till full enteral feeding

    Time frame: within first 2 years of life

  9. presence of gastro-esophagal reflux

    Time frame: at discharge

  10. day of surgery

    Time frame: within hospital stay

  11. requirement for use of patch for repair

    Time frame: at the time of postnatal surgery

  12. bronchopulmonary dysplasia

    Time frame: with the first 8 weeks

    defined as oxygen need for at least 28 days

  13. Need for Extracorporeal membrane oxygenation

    Time frame: during NICU admission

  14. Defect size

    Time frame: at the time of postnatal surgery

  15. number of days alive in case of postnatal death

    Time frame: during NICU admission

Sponsors and collaborators

Lead sponsor

University Hospital, Gasthuisberg

Other

Collaborators

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
  • Hopital Antoine Beclere
  • Hospital Clinic of Barcelona
  • King's College Hospital NHS Trust
  • Mater Mothers' Hospital
  • Medical University of Warsaw
  • Mount Sinai Hospital, Canada
  • National Center for Child Health and Development, Japan
  • Ospedale Pediatrico Bambino Gesù, Rome (IT)
  • The University of Texas Health Science Center, Houston
  • University Hospital, Bonn

Registry information

Official study title

Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left Sided and Isolated Congenital Diaphragma Hernia and Severe Pulmonary Hypoplasia.

Acronym: TOTAL

Important dates

Study start
2011
Primary completion
2020
Study completion
2020
First posted
Nov 15, 2010
Registry last updated
May 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.